Ming-Hui Zou, an internationally recognized researcher in molecular and translational medicine and a Georgia Research Alliance Eminent Scholar in Molecular Medicine and associate vice president for research at Georgia State University, is the founding director of the Center for Molecular and Translational Medicine at Georgia State.

He holds a doctorate and medical degree and has received prestigious awards from the Juvenile Diabetes Foundation International and the American Heart Association, including the Career Development Award, Irvin H. Page Atherosclerosis Research Award, and National Established Investigator Award.

Zou studies the role of oxidative stress in cardiovascular biology and diseases. He is recognized for making influential discoveries in cardiovascular research, including identifying the role of two key proteins involved in the vessel pathology that leads to vascular diseases and characterizing the AMP-activated kinase (AMPK), a key enzyme in the regulation of energy metabolism, obesity, diabetes, and cardiovascular diseases, as a sensor and regulator of oxidative stress in cardio-metabolic syndromes.